Scientists have found why people who sleep fewer than seven hours every night are at greater risk of stroke and heart attack.
The research, published in the journal Experimental Physiology, shows that sleep deprivation can increase the level of three physiological regulators (microRNAs) in the blood, which influence gene expression and play a key role in maintaining vascular health.
The findings could potentially lead to new, non-invasive tests for sleep deprived patients concerned about their health, according to researchers from University of Colorado Boulder in the US.
"This study proposes a new potential mechanism through which sleep influences heart health and overall physiology," said Christopher DeSouza, a professor at UC Boulder.
MicroRNAs are small molecules that suppress gene expression of certain proteins in cells.
The exact function of circulating microRNAs in the cardiovascular system, and their impact on cardiovascular health is receiving a lot of scientific attention, and drugs are currently in development for a variety of diseases, including cancer, to correct impaired microRNA signatures.
"They are like cellular brakes, so if beneficial microRNAs are lacking that can have a big impact on the health of the cell," said DeSouza.
For the study, which is the first to explore the impact of insufficient sleep on circulating microRNA signatures, researchers took blood samples from 24 healthy men and women, age 44 to 62, who had filled out questionnaires about their sleep habits.
Half slept seven to 8.5 hours nightly while the other half slept 5 to 6.8 hours nightly.
They measured expression of nine microRNAs previously associated with inflammation, immune function or vascular health.
They found that people with insufficient sleep had 40 to 60 percent lower circulating levels of miR-125A, miR-126, and miR-146a than those who slept enough.
"Why 7 or 8 hours seems to be the magic number is unclear," said DeSouza.
"However, it is plausible that people need at least seven hours of sleep per night to maintain levels of important physiological regulators, such as microRNAs," he said.
It is possible that microRNAs in blood could be used as a marker of cardiovascular disease in people with insufficient sleep, enabling doctors to glean important information via a blood test rather than current, more invasive tests, researchers said.
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
